Our hosting provider is investigating network issues. We apologize for the inconvenience.

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

Cancer cell | Apr 13, 2010

The biologic and clinical significance of KIT overexpression that associates with KIT gain-of-function mutations occurring in subsets of acute myeloid leukemia (AML) (i.e., core binding factor AML) is unknown. Here, we show that KIT mutations lead to MYC-dependent miR-29b repression and increased levels of the miR-29b target Sp1 in KIT-driven leukemia. Sp1 enhances its own expression by participating in a NFkappaB/HDAC complex that further represses miR-29b transcription. Upregulated Sp1 then binds NFkappaB and transactivates KIT. Therefore, activated KIT ultimately induces its own transcription. Our results provide evidence that the mechanisms of Sp1/NFkappaB/HDAC/miR-29b-dependent KIT overexpression contribute to leukemia growth and can be successfully targeted by pharmacological disruption of the Sp1/NFkappaB/HDAC complex or synthetic miR-29b treatment in KIT-driven AML.

Pubmed ID: 20385359 RIS Download

Mesh terms: Cell Line, Tumor | Chromosomes, Human, Pair 7 | Gene Expression Regulation, Neoplastic | Genetic Vectors | Histone Deacetylases | Homeostasis | Humans | Immunoglobulins | Leukemia, Myeloid | MicroRNAs | NF-kappa B | Proto-Oncogene Proteins c-kit | Transcription, Genetic

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: P50 CA140158
  • Agency: NCI NIH HHS, Id: R01 CA102031
  • Agency: NCI NIH HHS, Id: CA140158
  • Agency: NCI NIH HHS, Id: CA102031
  • Agency: NCI NIH HHS, Id: CA101140
  • Agency: NCI NIH HHS, Id: U10 CA077658
  • Agency: NCI NIH HHS, Id: CA077658
  • Agency: NCI NIH HHS, Id: U24 CA114725
  • Agency: NCI NIH HHS, Id: R01 CA095512
  • Agency: NCI NIH HHS, Id: U10 CA101140
  • Agency: NCI NIH HHS, Id: R01 CA102031-07
  • Agency: NCRR NIH HHS, Id: UL1 RR025755
  • Agency: NCI NIH HHS, Id: CA114725

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.